Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;8(7):497-517.
doi: 10.1038/s41570-024-00618-x. Epub 2024 Jun 18.

Atroposelective catalysis

Affiliations
Review

Atroposelective catalysis

Tanno A Schmidt et al. Nat Rev Chem. 2024 Jul.

Abstract

Atropisomeric compounds-stereoisomers that arise from the restricted rotation about a single bond-have attracted widespread attention in recent years due to their immense potential for applications in a variety of fields, including medicinal chemistry, catalysis and molecular nanoscience. This increased interest led to the invention of new molecular motors, the incorporation of atropisomers into drug discovery programmes and a wide range of novel atroposelective reactions, including those that simultaneously control multiple stereogenic axes. A diverse set of synthetic methodologies, which can be grouped into desymmetrizations, (dynamic) kinetic resolutions, cross-coupling reactions and de novo ring formations, is available for the catalyst-controlled stereoselective synthesis of various atropisomer classes. In this Review, we generalize the concepts for the catalyst-controlled stereoselective synthesis of atropisomers within these categories with an emphasis on recent advancements and underdeveloped atropisomeric scaffolds beyond stereogenic C(sp2)-C(sp2) axes. We also discuss more complex systems with multiple stereogenic axes or higher-order stereogenicity.

PubMed Disclaimer

References

    1. Ōki, M. Isolation of rotational isomers and developments derived therefrom. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86, 867–883 (2010). - PubMed - PMC
    1. Smyth, J. E., Butler, N. M. & Keller, P. A. A twist of nature – the significance of atropisomers in biological systems. Nat. Prod. Rep. 32, 1562–1583 (2015). - PubMed
    1. Clayden, J., Moran, W. J., Edwards, P. J. & LaPlante, S. R. The challenge of atropisomerism in drug discovery. Angew. Chem. Int. Ed. 48, 6398–6401 (2009).
    1. LaPlante, S. R., Edwards, P. J., Fader, L. D., Jakalian, A. & Hucke, O. Revealing atropisomer axial chirality in drug discovery. ChemMedChem 6, 505–513 (2011). - PubMed
    1. Perreault, S., Chandrasekhar, J. & Patel, L. Atropisomerism in drug discovery: a medicinal chemistry perspective inspired by atropisomeric class I PI3K inhibitors. Acc. Chem. Res. 55, 2581–2593 (2022). - PubMed

LinkOut - more resources